Clinical Trial Update: Validity of Brain Metastasis Risk Predictive Model in Hormone Positive Breast Cancer Patients

View source ↗

Summary

A study is planned to validate a brain metastasis risk predictive model in patients with hormone receptor-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Assiut University | Conditions: Breast Cancer, Estrogen Receptor-Positive | Status: NOT_YET_RECRUITING